December 5, 2018

Wednesday, December 5

5:00 – 6:00

Registration & Networking

6:00 – 6:05

Welcome and Opening Remarks

Bob Buderi, Xconomy

6:10 – 6:40

The RDMD Story

Sparked from a Silicon Valley hackathon, RDMD is building repositories of patient health data to encourage new drugs for rare diseases.

Introduction: Tiffany Reiter, Fish & Richardson
Nancy Yu, RDMD
Onno Faber, RDMD
Tristen Moors, Modis Therapeutics

6:45 – 7:15

The Cortexyme Story

With more than $90 million in funding, drug developer Cortexyme thinks bacteria in the brain could be at play with Alzheimer’s and other neurodegenerative diseases.

Casey Lynch, Cortexyme
David Dolby, Dolby Family Ventures

7:15 – 7:45

The Allogene Therapeutics Story

Allogene is developing what it hopes will be more affordable cancer cell therapies for a wider range of cancer patients, made from donor cells rather than a patient’s own T cells.

David Chang, Allogene Therapeutics
Alison Moore, Allogene Therapeutics
Wendell Lim, UCSF Center for Systems & Synthetic Biology
Alex Lash, Xconomy (moderator)

7:45 – 8:45

Networking Reception

Please note that this schedule is subject to change.